Essays about: "Trastuzumab"
Showing result 1 - 5 of 7 essays containing the word Trastuzumab.
-
1. Phenol-Protein Solution Stability
University essay from Lunds universitet/Livsmedelsteknik och nutrition (master)Abstract : Phenol is a commonly used preservative in pharmaceutical protein solutions. It is compatible with most proteins but can cause aggregation and denaturation at higher concentrations or in more sensitive proteins. READ MORE
-
2. Quality and Regulatory Issues Related to Continuous Manufacturing of Biologics
University essay from Lunds universitet/Livsmedelsteknik och nutrition (master)Abstract : Introduction: Continuous Manufacturing involves the continuous feeding of input materials into the transformation of in-process materials within, and the concomitant removal of output materials from a manufacturing process based on ICH guideline. In these systems, all the processes from raw material to final finished product would be continuously produced. READ MORE
-
3. Development of an AVI-tagged phagemid vector
University essay from KTH/ProteinvetenskapAbstract : Fagmider är ett kraftfullt verktyg som använts för att uttrycka heterologa proteiner på fagvirus i metoder som exempelvis riktad evolution via fagdisplay av proteinbinliotek. Monovalent uttryck genom fagemider lider av ett överflöd av kala fager som är svåra att rensa bort. READ MORE
-
4. Trastuzumab in breast cancer metastatic setting: a retrospective study of clinical predictors of exceptional responders
University essay from Örebro universitet/Institutionen för medicinska vetenskaperAbstract : Background Currently,human epidermal growth factor 2(HER2)-positive, metastaticbreast cancer is considered an incurable disease;however, a small group can remain in long-term remission with theuse of anti-HER2 treatment. This small group of exceptional responders may beclinicallycured. READ MORE
-
5. Efficacy of trastuzumab-emtansine in breast cancer patients prior treated with pertuzumab
University essay from Örebro universitet/Institutionen för medicinska vetenskaperAbstract : Background:T-DM1 is preferred treatment option as2ndline treatmentinpatients with metastatic HER2-positive breast cancer after progression in trastuzumab-based 1stline treatment. When T-DM1 became the preferred treatment strategy as2ndline therapy,the1stline treatment did not include pertuzumabwhich is currently standard of care. READ MORE